AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

Also in today’s newsletter, US regulators plan to investigate Microsoft’s cloud business, and Disney-Reliance Indian media giant says TV ‘is not dead’ ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

The headline equity benchmarks continued their downward trend on Thursday, marking the sixth consecutive day of losses. The Nifty 50 index settled below the 23,550 mark, having reached a days high of ...

AstraZeneca PLC Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AZN ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

The CNS Summit Digital Innovation Index, developed in conjunction with IDEA Pharma, was revealed at the CNS Summit annual meeting on November 13. The index evaluates and ranks biopharma companies' ...

Shares in European vaccine-makers fell in early trade on Friday after U.S. President-elect Donald Trump said he had selected ...

Vaccine maker shares closed lower Thursday amid reports that Donald Trump was set to nominate vaccine critic Robert F.

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

Home prices in major Chinese cities posted narrower declines in October when compared with September as Beijing's property support measures start to kick in. Average new home prices in 70 Chinese ...

All 11 sectors are in the green for the year. The optimism comes as the economy is likely to continue to grow because the ...